Cyclacel Pharmaceuticals, Inc. 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Feb 20, 2015
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Award
Option
2015-02-18+53,095→ 53,095 totalExercise: $0.86Exp: 2025-02-18→ Common Stock (53,095 underlying)
Footnotes (2)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were granted to Mr. McBarron under the Issuer's Amended and Restated 2006 Equity Incentive Plan as part of the Issuer's annual equity compensation to executive officers.